Why the study?
Do preoperative circulating IGF system components predict treatment outcome in patients with epithelial ovarian cancer?
Population
228 patients with epithelial ovarian cancer at two tertiary centers
Design
Cohort
Follow-up
median 44 months
Authors
Loading...
May support IGFBP2 as a prognostic marker in ovarian cancer; leaves open prospective validation before clinical use.
Do preoperative circulating IGF system components predict treatment outcome in patients with epithelial ovarian cancer?
Elevated serum IGFBP2 levels at diagnosis are an independent predictor of mortality in patients with epithelial ovarian cancer.
Huang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: